Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease

PHASE2RecruitingINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

March 13, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

October 31, 2025

Conditions
Parkinson Disease
Interventions
DRUG

Lenrispodun

Lenrispodun 30 mg tablets administered orally, once daily.

DRUG

Placebo

Matching tablets administered orally, once daily.

Trial Locations (31)

12208

NOT_YET_RECRUITING

Clinical Site, Albany

22042

RECRUITING

Clinical Site, Falls Church

23233

RECRUITING

Clinical Site, Henrico

29732

RECRUITING

Clinical Site, Rock Hill

30030

RECRUITING

Clinical Site, Decatur

30912

RECRUITING

Clinical Site, Augusta

32127

RECRUITING

Clinical Site, Port Orange

32714

RECRUITING

Clinical Site, Altamonte Springs

32751

NOT_YET_RECRUITING

Clinical Site, Maitland

32804

RECRUITING

Clinical Site, Orlando

32825

RECRUITING

Clinical Site, Orlando

33009

RECRUITING

Clinical Site, Hallandale

33067

RECRUITING

Clinical Site, Coral Springs

33136

RECRUITING

Clinical Site, Miami

33486

RECRUITING

Clinical Site, Boca Raton

33612

RECRUITING

Clinical Site, Tampa

34470

RECRUITING

Clinical Site, Ocala

38157

RECRUITING

Clinical Site, Memphis

48334

RECRUITING

Clinical Site, Farmington Hills

53226

RECRUITING

Clinical Site, Milwaukee

55427

RECRUITING

Clinical Site, Golden Valley

66160

RECRUITING

Clinical Site, Kansas City

75243

RECRUITING

Clinical Site, Dallas

78628

RECRUITING

Clinical Site, Georgetown

78746

RECRUITING

Clinical Site, Austin

85013

RECRUITING

Clinical Site, Phoenix

85251

RECRUITING

Clinical Site, Scottsdale

92354

RECRUITING

Clinical Site, Loma Linda

92697

RECRUITING

Clinical Site, Irvine

98034

RECRUITING

Clinical Site, Kirkland

99202

RECRUITING

Clinical Site, Spokane

Sponsors
All Listed Sponsors
lead

Intra-Cellular Therapies, Inc.

INDUSTRY